Moody's assigned a P-3 rating to Fresenius Medical Care's guaranteed US commercial paper program. Its existing ratings and stable outlook stayed unchanged, so the report does not point to a change in the company's prospects.
This sets a short-term credit label for one borrowing program. It does not report a change to Fresenius Medical Care's other ratings or its stable outlook, so it gives no clear new reason to expect the company's prospects to improve or worsen.
Follow Fresenius Medical Care AG (FMS) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for FMS